Zacks.com users have been paying close attention to Novo Nordisk (NVO). This makes it worthwhile to examine what the stock has in store.

I've been a Novo Nordisk bull for quite some time now, and I wouldn't be as spooked by the situation. Here's why. Novo Nordisk got a two-year-plus head start in the white-hot obesity drugs market, ...

FDA seizes hundreds of fake Ozempic units from US supply after Novo Nordisk alerts regulators to counterfeit semaglutide ...

Wall Street gains as S&P 500 surpasses 6,000; key healthcare stock movers revealed. Explore top deals, trends, and regulatory updates in the sector.

The NHS is reported to be in line for a £30 billion ($40.7 billion) increase to its budget in the UK government's upcoming ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Oracle Corp. (ORCL), Novo Nordisk A/S ...

This World Cycling Day, let us embrace the spirit of cycling—a pursuit that connects individuals, fosters resilience, and ...

About 23% and 19% of the spironolactone and placebo groups discontinued treatment, respectively. The majority of treatment ...

Many companies have failed to disrupt the complicated U.S. healthcare market. Hims & Hers (NYSE: HIMS) may finally be ...

Diving into the complexities of sustainability within healthcare packaging that include circular economy strategies, takeback ...

Led by researchers at NYU Grossman School of Medicine, the study reveals key details about how cells process fuels like ...

The Institute of Medicine of Chicago is celebrating its 110th Anniversary & 2025 Annual Leadership Awards on June 26, 2025, from 5:00 PM to 8:00 PM CT at Maggiano's-Chicago. This convening is the ...